<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00412438</url>
  </required_header>
  <id_info>
    <org_study_id>RIEM-G-1</org_study_id>
    <nct_id>NCT00412438</nct_id>
  </id_info>
  <brief_title>Investigation of Genetic Risk of Atrial Fibrillation</brief_title>
  <official_title>Investigation of Genetic Risk of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nagoya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nagoya University</source>
  <brief_summary>
    <textblock>
      The atrial fibrillation (AF) is the most common cardiac rhythm disturbance that is
      responsible for substantial morbidity and mortality independent of associated heart disease
      or other risk factors. Even in the absence of preexisting cardiovascular disease, AF remains
      significantly associated with excess mortality rates. The current unsatisfactory treatment
      for AF comes from lack of understanding of the pathophysiology of AF. The purpose of this
      study is to identify gene polymorphisms that confer susceptibility to atrial fibrillation.
      Patients with AF（N=500） and healthy volunteer（N=1000） without AF are enrolled in this study.
      Patients with coronary artery disease, severe valvular heart disease, cardiomyopathy or heart
      failure were excluded from the study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control, Natural History</observational_model>
    <time_perspective>Cross-Sectional, Retrospective</time_perspective>
  </study_design_info>
  <enrollment>1000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of atrial fibirillation

        Exclusion Criteria:

          -  coronary artery disease

          -  severe valvular heart disease

          -  cardiomyopathy

          -  heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenji Yasui, MD, Phd</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Bio-information Analysis, Research Institute of Enviromental Medicine, Nagoya University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kenji Yasui, MD, PhD</last_name>
    <phone>+81-52-788-6211</phone>
    <email>kenji@riem.nagoya-u.ac.jp</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Masaki Yamauchi, MD</last_name>
    <phone>+81-52-788-6210</phone>
    <email>g030744d@mbox.nagoya-u.ac.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Bio-information Analysis, Research Institute of Enviromental Medicine, Nagoya University</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenji Yasui, MD, PhD</last_name>
      <phone>+81-52-6211</phone>
      <email>kenji@riem.nagoya-u.ac.jp</email>
    </contact>
    <contact_backup>
      <last_name>Masaki Yamauchi, MD</last_name>
      <phone>+81-52-6211</phone>
      <email>g030744d@mbox.nagoya-u.ac.jp</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2006</study_first_submitted>
  <study_first_submitted_qc>December 15, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2006</study_first_posted>
  <last_update_submitted>December 15, 2006</last_update_submitted>
  <last_update_submitted_qc>December 15, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2006</last_update_posted>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

